TA
Tatva Chintan Pharma Chem Ltd (TATVA)
₹1,601.80
Mkt cap
₹3,937 Cr
P/E ratio
61.60
P/B
4.60
Div yield
0.12%
ROE
5.54%
ROCE
7.18%
EPS (TTM)
₹26.00
Book value
₹348
52W range
1,044–2,114
Sector
Commodities
Price history
Previous close
Tatva Chintan Pharma Chem Limited was incorporated in 1996 and it is a manufacturer of a diverse portfolio of structure Directing Agents, Phase Transfer Catalysts, electrolyte salts for batteries, and Pharmaceutical and Agrochemical Intermediates and other Speciality chemicals [1]
NSE TATVABSE 543321
Health check
Cautious
ValuationExpensive
ProfitabilityWeak
GrowthHigh
TechnicalsNeutral
52-week range
−24.21% from high₹1,602
₹1,044+53.41% from low₹2,114
Current
₹1,601.80
Prev close
₹1,637.20
Day
−2.16%
Price performance
1D
−2.58%
1W
−5.22%
1M
−4.15%
3M
−2.65%
6M
+34.29%
1Y
+7.09%
YTD
+15.34%
Financials
Revenue, profit & margin
P/E ratio
61.6×
TATVA is 138% above the sector median of 25.9×
TATVA61.6×
Sector median25.9×
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 97 | 84 | 98 | 105 | 83 | 86 | 108 | 117 | 124 | 131 | 134 | 167 | 217 | |
| YoY Sales growth | +7% | -30% | -21% | -8% | -14% | +2% | +10% | +11% | +48% | +53% | +24% | +43% | +76% | |
| Expenses | 76 | 73 | 83 | 93 | 78 | 79 | 99 | 100 | 101 | 106 | 106 | 135 | 177 | |
| Operating Profit | 20 | 11 | 16 | 13 | 6 | 7 | 9 | 17 | 22 | 25 | 28 | 32 | 41 | |
| OPM % | 21% | 13% | 16% | 12% | 7% | 8% | 8% | 15% | 18% | 19% | 21% | 19% | 19% | |
| Other Income | 1 | 1 | 5 | 1 | 0 | 0 | 1 | 1 | 1 | 2 | -0 | 1 | 2 | |
| Interest | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 2 | 3 | |
| Depreciation | 7 | 7 | 6 | 7 | 7 | 7 | 7 | 9 | 9 | 9 | 10 | 11 | 11 | |
| Profit before tax | 11 | 5 | 14 | 7 | -1 | -0 | 2 | 9 | 14 | 18 | 17 | 21 | 29 | |
| Tax % | 31% | 34% | 30% | 24% | -34% | -165% | 49% | 27% | 27% | 14% | 38% | 24% | 26% | |
| Net Profit | 8 | 3 | 10 | 5 | -1 | 0 | 1 | 7 | 10 | 15 | 10 | 16 | 21 | |
| EPS in Rs | 3.33 | 1.48 | 4.11 | 2.23 | -0.28 | 0.06 | 0.44 | 2.84 | 4.24 | 6.49 | 4.41 | 6.83 | 9.17 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −0.70% · closed higher next day 0 of last 1
| Q2FY27 | |
|---|---|
| Broadcast | 19 Oct '26◦ |
| Earnings day | −0.70% |
| +1 day | −12.57% |
| +5 days | −14.48% |
| +15 days | −12.79% |
| +30 days | — |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Sep 202672.02%Promoter
Promoters72.02%
FIIs4.38%0.45
DIIs3.21%0.10
Public20.39%0.55
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Pidilite Inds. | ₹1,525.70 | 57.90 | 1,55,399 | 0.75% | 626 | +6.09% | 4,298 | +20.91% | 31.02% |
| Gujarat Fluoroch | ₹4,712.10 | 75.93 | 51,762 | 0.06% | 240 | +35.75% | 1,760 | +45.45% | 9.64% |
| Navin Fluo.Intl. | ₹10,002.00 | 56.02 | 51,325 | 0.15% | 269 | +81.46% | 1,191 | +57.00% | 20.96% |
| Aether Industri. | ₹1,677.20 | 88.34 | 22,263 | 0.00% | 68 | +21.62% | 347 | +23.96% | 11.92% |
| Deepak Nitrite | ₹1,594.40 | 20.30 | 21,747 | 0.47% | 398 | +234.99% | 3,076 | +61.75% | 11.37% |
| Aarti Industries | ₹481.95 | 28.84 | 17,482 | 0.21% | 168 | +100.00% | 3,669 | +74.71% | 6.86% |
| Fine Organic | ₹5,299.50 | 33.73 | 16,248 | 0.21% | 152 | +40.14% | 729 | +22.12% | 21.47% |
| Tatva Chintan | ₹1,682.90 | 61.59 | 3,937 | 0.12% | 21 | +116.23% | 217 | +75.94% | 7.18% |
| Median: 96 Co. | ₹322.57 | 25.91 | 849 | 0.23% | 10 | +35.75% | 172 | +28.49% | 14.16% |
Filings
Annual reports6
Concall transcripts51
TranscriptMay 2024PPTOct 2026PPTOct 2026TranscriptJul 2026PPTJul 2026RECJul 2026TranscriptMay 2026PPTMay 2026RECMay 2026TranscriptJan 2026PPTJan 2026RECJan 2026TranscriptNov 2025PPTNov 2025RECNov 2025TranscriptJul 2025PPTJul 2025RECJul 2025TranscriptMay 2025PPTMay 2025TranscriptJan 2025PPTJan 2025TranscriptOct 2024PPTOct 2024
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Newspaper Publication 20 Oct - Newspaper Publication of Extract of Financial Results of the Company for the quarter and half year ended 30 September 2026.Updated Investor Presentation 19 OctAnnouncement under Regulation 30 (LODR)-Investor Presentation 19 Oct - Investor Presentation for the quarter and half year ended 30 September 2026.Intimation Regarding Cancellation Of Schedule Of Earnings Call 19 Oct - Tatva Chintan cancelled its 19 October 2026 earnings call due to unforeseen circumstances.Board Meeting Outcome for Board Meeting Outcome For Outcome Of The Board Meeting Held On 19.10.2026 19 Oct - Standalone and consolidated Q2 and half-year FY2026-27 unaudited financial results approved on 19 October 2026.






